Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Flavonoids Kill Human Pancreatic Cancer Cells

By BiotechDaily International staff writers
Posted on 26 Aug 2013
Flavonoids in celery, artichokes, and especially Mexican oregano contain flavonoids that kill human pancreatic cancer cells by enzymatic inhibition, according to a new study.

Two researchers at the University of Illinois (UIC; Chicago, IL, USA) examined the inhibitory effects of flavonoids, limonoids, phenolic acids, and ascorbic acid citrus fruit bioactive compounds on BxPC-3 and PANC-1 human pancreatic cancer cells in vitro, focusing on the antiproliferative mechanism of action of the flavonoid apigenin as related to the glycogen synthase kinase-3β (GSK-3β) nuclear factor kappa B signaling pathway.

The researchers found that apigenin inhibited the GSK-3β enzymatic pathway, leading to a decrease in the production of antiapoptotic genes in the pancreatic cancer cells, thus encouraging the cancer cells to self-destruct via apoptosis. In one of the cancer cell lines, the percentage of cells undergoing apoptosis went from 8.4% in cells that had not been treated with the flavonoid to 43.8% in cells that had been treated with a 50-micromolar dose. Treatment with the flavonoid also modified gene expression, causing upregulation of certain genes associated with pro-inflammatory cytokines such interleukin 17. The study was published on August 13, 2013, in Molecular Nutrition and Food Research.

“Apigenin alone induced cell death in two aggressive human pancreatic cancer cell lines. But we received the best results when we pretreated cancer cells with apigenin for 24 hours, then applied the chemotherapeutic drug gemcitabine for 36 hours,” said study coauthor professor Elvira de Mejia, PhD. “Pancreatic cancer patients would probably not be able to eat enough flavonoid-rich foods to raise blood plasma levels of the flavonoid to an effective level. But scientists could design drugs that would achieve those concentrations.”

“The trick seemed to be using the flavonoids as a pretreatment instead of applying them and the chemotherapeutic drug simultaneously. Even though the topic is still controversial, our study indicated that taking antioxidant supplements on the same day as chemotherapeutic drugs may negate the effect of those drugs,” added coauthor Jodee Johnson, PhD. “That happens because flavonoids can act as antioxidants. One of the ways that chemotherapeutic drugs kill cells is based on their pro-oxidant activity, meaning that flavonoids and chemotherapeutic drugs may compete with each other when they're introduced at the same time.”

Flavonoids are a class of plant secondary metabolites that may modify allergens, viruses, and carcinogens, and demonstrate significant antioxidant activity in vitro that may be stronger than those of vitamin C and E. However, inside the human body, they have little or no direct antioxidant value, since flavonoids are poorly absorbed (less than 5%), with most of what is absorbed being quickly metabolized and excreted.

Related Links:

University of Illinois




RANDOX LABORATORIES
BIOSIGMA S.R.L.
SLAS - Society for Laboratory Automation and Screening
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: The Human Protein Atlas is tissue-based map of the human proteome (Photo courtesy of the Human Protein Atlas).

Open Source Tissue-Based Map of the Human Proteome Launched

Constructed with 13 million annotated images, an interactive database has been created to show the distribution of proteins in all major tissues and organs of the human body. Ten years after the completion... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.